By Tarun Sai Lomte Reviewed by Susha Cheriyedath, M.Sc. Jun 24 2026 New Korean health-screening data suggest prompt antidiabetic treatment after type 2 diabetes thresholds are crossed may improve survival, while the cardiovascular benefits remain promising but unproven. In a recent study published in the journal JAMA Network Open , researchers investigated associations between the timing of antidiabetic medication ( ADM ) initiation and the risk of major adverse cardiovascular events ( MACE )